Roger Michael Gendreau - Dec 4, 2025 Form 4 Insider Report for Dogwood Therapeutics, Inc. (DWTX)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Greg Duncan, Attorney-in-Fact
Stock symbol
DWTX
Transactions as of
Dec 4, 2025
Transactions value $
$0
Form type
4
Date filed
12/5/2025, 04:05 PM
Previous filing
Jul 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gendreau Roger Michael CHIEF MEDICAL OFFICER C/O DOGWOOD THERAPEUTICS, INC., 44 MILTON AVENUE, ALPHARETTA /s/ Greg Duncan, Attorney-in-Fact 2025-12-05 0001826131

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DWTX Stock Option (right to buy) Award $0 +150K $0.00 150K Dec 4, 2025 Common Stock 150K $6.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests one-third on December 4, 2026 and 1/24th monthly thereafter.